HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

Dr. Prasad , M.B.B.S., D.M.R.T, M.D.
Oncologist, Radiation
Chennai, Tamilnadu, India

1
Rating:
4.6 stars (5 ratings)
1 User viewed this profile
Certified Expert Certified Expert
Certified Expert 1 answer voted Helpful
Certified Expert 5 Answered 0 premium & 5 public questions
Be the First one to like this doctor

Contact Details
 
City
Chennai
State
Tamilnadu
Country
India

Professional Details
 
State Licence Number/NPI
74386
State/Board registered with
TAMILNADU MEDICAL COUNCIL
Specialty
Oncologist, Radiation
Years of experience
15
Patients seen per week
150 
Procedures done per week
10 
Specific Skills and Interests
Gynecologic Oncology
Head and neck Oncology
Breast cancers
Neuro oncology
Thoracic Oncology 
 

Education Details
 
Graduation
 
Year
2004 
Degree earned
M.B.B.S. 
Name of the university
GOVT. STANLEY MEDICAL COLLEGE 
Residency / Post graduation
 
Year of post-graduation
2006
Degree earned
D.M.R.T
University/Hospital/Institute
MADRAS MEDICAL COLLEGE 
Fellowship / Specialty Training
 
Year of fellowship
2008
Degree earned
M.D.
University/Hospital/Institute
CHRISTIAN MEDICAL COLLEGE 

Other Details
 
Honors/Awards
 
Affiliations
•     Life member – AROI (Association of Radiation Oncologists of India)
•     Life member – IBS (Indian Brachytherapy Society)
•     Life member – ICON (Indian Cooperative Oncology Network)
•     Member – ABS (American Brachytherapy Society)
•     Member – IGCS (International Gynecologic Cancer Society)
 
Other professional achievements
PUBLICATION
•     Eswaran P, Devadoss P, Kannan K. “Monophasic Synovial Sarcoma of the Heart – A case report and Review of Literature” – Status – Accepted for Publication - Journal of Cancer Research and Therapeutics.
•     Eswaran P, Azmi KS. “Concurrent chemoradiation with weekly Cisplatin, Docetaxel and Gefitinib: A study to assess feasibility, toxicity and immediate response”. Journal of Cancer Research and Therapeutics 2013;Vol 9:Pg 392-6 (Jul – Sep 2013). PMID: 24125972.
•     Prasad E, Viswanathan P N, Faith Rangad V, Thomas Ram, Pavamani S et al. “Maximum Tolerated Dose - Results of Phase I trial of weekly Paclitaxel and Cisplatin with Radiation Therapy in Carcinoma Cervix” – Clinical Oncology, Vol 21, Iss 6, Pg 488-493 (August 2009). PMID: 19386478.

PUBLICATION (as abstracts)
•     Eswaran P, Kumaravelu AS. Toxicity & Response Assessment with Prolonged Infusion Gemcitabine and Gefitinib With Intensity Modulated Radiation Therapy In Recurrent Head And Neck Squamous Cell Carcinoma - A Pilot Study. Abstract No. 2767, Page S 505. International Journal of Radiation Oncology*Biology*Physics. 2012 Oct:Vol 84, Iss 3, Suppl, Pages A1-A36, S1-S908 (1 November 2012). http://download.journals.elsevierhealth.com/pdfs/journals/0360-3016/PIIS0360301612022912.pdf
•     Eswaran P, Kumaravelu AS. Gemcitabine with Intensity Modulated Radiation Therapy in Recurrent Cervical Squamous Cell Carcinoma - A Pilot Study. Poster Session II – Page E602. The International Journal of Gynecological Cancer – October 2012, Volume 22, Issue 8, Supplement 3.
•     Eswaran P, Kumaravelu AS. Concurrent Chemoradiation with weekly Cisplatin, Docetaxel and Gefitinib – A study to assess feasibility, toxicity and immediate response. (2012, July 21) – Abstracts of 8th AHNS http://ahns.jnabstracts.com/2012/Detail.aspx?ID=0055.
•     Kumaravelu AS, Eswaran P. Palliative Hypofractionated Radiotherapy and Chemotherapy in advanced Head and Neck Squamous Cell Carcinoma (HNSCC). Journal of Supportive Care in Cancer. 2012 Jun; 20(Suppl 1): S1-S283. PMID: 22669607.
•     P. Eswaran. Palliation of Symptoms in Recurrent Cervical Cancer patients. Journal of Supportive care in Cancer. 2011 Jun; 19 (Suppl2):S67-S370. PMID: 21656340.
•     P. Eswaran. Role of Upfront HDR Brachytherapy in Dysphagia Palliation in esophageal Malignancies. Journal of Supportive care in Cancer. 2011 Jun; 19(Suppl 2): S67 - S370. PMID: 21656340.